Skip to main content
SpringerLink
Log in

Combined Hyperthermia and Chemotherapy for Malignant Melanoma of the Limbs

  • Chapter
Interstitial, Endocavitary and Perfusional Hyperthermia

Part of the book series: Clinical Thermology ((1289))

Abstract

Malignant melanoma represents about 5% of skin cancers and 2% of malignant tumors (excluding the other skin cancers). Its incidence is extremely variable and is evaluated at 0.3/100000 inhabitants in Japan and up to 40/100000 inhabitants in Queensland, Australia, a number which is considered the highest in the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman LV, Del Regato JA (1962) Malignant melanoma of the skin. In: Cancer: diagnosis, treatment, and prognosis. Mosby -cV, St Louis

    Google Scholar 

  2. Aigner KR, Hüd P, Hundeiker M (1981) Neue Entwicklungen in der isolierten Extremitäten Perfusion. Z Hautkr 57:1044–1054

    Google Scholar 

  3. Aigner KR, Walther H, Link KH, Voigt H (1986) Perfusionstherapie. In: Voigt H, Kleeber UR (eds) Malignes Melanom. Springer, Berlin Heidelberg New York, pp 299–305

    Chapter  Google Scholar 

  4. Bulman AS, Jamieson CW (1980) Isolated limb perfusion with melphalan in the treatment of malignant melanoma. Br J Surg 67: 660–662

    Article  PubMed  CAS  Google Scholar 

  5. Cavalière R, Ciocatto E, Giovanella B, Heidelberger C, Johnson R, Magottini M, Mondovi B, Moricca G, Rossi-Favelli A (1967) Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 20:1351–1381

    Article  PubMed  Google Scholar 

  6. Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632

    Article  PubMed  Google Scholar 

  7. Cruchley PM, Kaplan JA, Waller JL, Youg MR (1982) Anesthesia for isolated hyperthermic limb perfusion. Anesthesiology 57:228–230

    Article  PubMed  CAS  Google Scholar 

  8. Cumberlin R, De Moss E, Lassus M, Freidman M (1985) Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 3:1022–1031

    PubMed  CAS  Google Scholar 

  9. Davis CD, Ivins JC, Soule EH (1976) Mayo Clinic experience with isolated limb perfusion for invasive malignant melanoma of the extremities. Proceedings of the ninth international pigment cell conference, Houston Texas. In: Riley R (ed) Pigment cell. Karger S, New York, pp 379–385

    Google Scholar 

  10. De Cosse JJ, Rogers LS (1966) Influence of high pressure oxygen and chemotherapy of the A. Mel 4 hamster melanoma. Cancer Res pt 1:287–292

    Google Scholar 

  11. Didolkar MS, Fitzpatrick JL, Jackson AJ, Johnson GS (1986) Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide in melanoma. Cancer 57:1961–1966

    Article  PubMed  CAS  Google Scholar 

  12. Fletcher JR, White CR, Fletcher WA (1986) Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy. Am J Surg 151:593–597

    Article  PubMed  CAS  Google Scholar 

  13. Fontijne WPJ, Mook PH, Schraffordt-Koops J, Oldhoff J, Wildevuur RH (1985) Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical study. Cancer 55:1455–1461

    Article  PubMed  CAS  Google Scholar 

  14. Ghussen F, Nagel K, Groth W (1981) Regionale hyper-therme Zytostatikaperfusion bei malignen Melanomen der Extremitäten. Dtsch Med Wochenschr 106:1612–1615

    Article  PubMed  CAS  Google Scholar 

  15. Ghussen F, Nagel K, Groth W, Müller JM, Stützer H (1984) A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg 200:764–768

    Article  PubMed  CAS  Google Scholar 

  16. Ghussen F, Kruger I, Groth W, Stützer H (1986) Randomized melanoma study of perfusion of the extremities. Results of treatment 21/2 years after premature discontinuation. Chirurg 57:619–623

    PubMed  CAS  Google Scholar 

  17. Ghussen F, Kruger I, Groth W, Stützer H (1988) The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 61:654–659

    Article  PubMed  CAS  Google Scholar 

  18. Golomb FM, Bromberg J, Dubin N (1979) A controlled study of the survival experience of patients with primary malignant melanoma of the distal extremities treated with adjuvant isolated perfusion. Adjuvant Ther Cancer 2:519–526

    Google Scholar 

  19. Gundersen S, Hager B, Tausjo J (1986) Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity. Cancer Treat Rev 70:1015–1017

    CAS  Google Scholar 

  20. Janoff KA, Moseson D, Nohlgren J, Davenport C, Richards C, Fletcher WS (1982) The treatment of stage I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg 196:316–323

    Article  PubMed  CAS  Google Scholar 

  21. Klein ES, Ben-Ari GY (1987) Isolation perfusion with cis-platin for malignant melanoma of the limbs. Cancer 59:1068–1071

    Article  PubMed  CAS  Google Scholar 

  22. Klopp C, Alford T, Bateman J, Berry G, Winship T (1950) Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride. A preliminary report. Ann Surg 132:811–832

    Article  PubMed  CAS  Google Scholar 

  23. Krementz ET (1986) Regional perfusion. Current sophistication, what next? Cancer 57:426–432

    Article  Google Scholar 

  24. Krementz ET, Knudson L (1961) The effect of increased oxygen tension on the tumoricidal effect of nitrogen mustard. Surgery 50:266–271

    PubMed  CAS  Google Scholar 

  25. Krementz ET, Ryan RF (1972) Chemotherapy of melanoma of the extremities by perfusion; fourteen years clinical experience. Ann Surg 175:900–917

    Article  PubMed  CAS  Google Scholar 

  26. Krementz ET, Carter RD, Sutherland CM, Campbell M (1979) The use of regional chemotherapy in the management of malignant melanoma. World J Surg 3:289–304

    Article  PubMed  CAS  Google Scholar 

  27. Krementz ET, Carter RD, Sutherland CM, Muchmore JH (1987) Chemotherapy by regional perfusion for limb melanoma. Am Surg 53:133–140

    PubMed  CAS  Google Scholar 

  28. Lee YTNM (1980) Loco-regional recurrent melanoma. I. Natural history. Cancer Treat Rev 7:59–72

    PubMed  CAS  Google Scholar 

  29. Lejeune F, Achten G (1983) Le mélanome malin cutané. Stratégies et résultats thérapeutiques. In: Le mélanome malin. XVIIe congrès de l’association des dermatologistes et syphiligraphes de langue française. Brussels, June 2–4, pp 249–291

    Google Scholar 

  30. Luck J (1956) Action of p-[di(2-chloroethylamino-L-phenylalanine] on Harding Passey mouse melanoma. Science 123:984–985

    Article  PubMed  CAS  Google Scholar 

  31. Martijn H, Olkhoff J, Schraffordt-Koops H, Oosterhuis J (1982) Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanoma of the extremities. J Surg Oncol 20:9–13

    Article  PubMed  CAS  Google Scholar 

  32. Martijn H, Oldhoff J, Oosterhuis JW, Schraffordt-Koops H (1983) Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion. Cancer 52:1526–1534

    Article  PubMed  CAS  Google Scholar 

  33. Martijn H, Schraffordt-Koops H, Milton GW, Nap M, Oosterhuis JW, Shaw HM, Oldhoff J (1986) Comparison of two methods of treating primary malignant melanomas Clark IV et V, thickness 1.5 mm and greater localized on the extremities. Cancer 57:1923–1930

    Article  PubMed  CAS  Google Scholar 

  34. McBride CM, Sugarbaker EV, Hickey RC (1975) Prophylactic isolation perfusion as the primary therapy for invasive malignant melanoma of the limbs. Ann Surg 182:316–324

    Article  PubMed  CAS  Google Scholar 

  35. Millar RD, Ketcham AS (1974) The effect of heparin and warfarin on primary and metastatic tumors. J Med 5:23–31

    PubMed  CAS  Google Scholar 

  36. Minor DR, Allen RE, Alberts D, Peng YM, Tardellin G, Hutchinson J (1985) A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer 55:2638–2644

    Article  PubMed  CAS  Google Scholar 

  37. Nachbur B (1986) Die Perfusionsbehandlung des Extremitä-tenmelanomas. Indikationen, Technik, Komplikationen und Ergebnisse der regionalen Perfusionsbehandlung des malignen Melanomas der Extremitäten. Huber, Bern, p 104

    Google Scholar 

  38. Rampen FHJ (1985) Towards a rational perfusion strategy for malignant melanoma. Eur J Surg Oncol 11:117–118

    PubMed  CAS  Google Scholar 

  39. Schraffordt-Koops H, Oldhoff J, Oosterhuis JW, Beekhuis H (1985) The role of isolated limb perfusion for regional metastases of the extremities. In: Balch CM (ed) Surgical approaches to cutaneous melanoma. Karger, Basel, pp 146–164 (Pigment Cell, vol 7.)

    Google Scholar 

  40. Shingleton WW, Seigler HF, Stocks LH, Downs RW (1975) Management of recurrent melanoma of the extremity. Cancer 35:574–579

    Article  PubMed  CAS  Google Scholar 

  41. Shiu MH, Knapper WH, Fortner JG, Yeh S, Horowitz G, Schnog J, Guerra J, Gould-Rossbach P, Ray C (1986) Regional isolated limb perfusion of melanoma in transit metastases using mechlorethamine (nitrogen mustard). J Clin Oncol 4:1819–1826

    PubMed  CAS  Google Scholar 

  42. Stehlin JS (1969) Hyperthermic perfusion with chemotherapy for cancers of the extremity. Surg Gynecol Obstet 129:305–308

    PubMed  Google Scholar 

  43. Stehlin JS, Giovanella BC, De Ipolyi PD, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140:339–348

    PubMed  CAS  Google Scholar 

  44. Storm FK, Morton DL (1985) Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity. Am J Surg 150:32–35

    Article  PubMed  CAS  Google Scholar 

  45. Storm FK, Silberman AW, Ramming KR, Kaiser LR, Harrison WH, Elliott RS, Haskell CM, Sarna G, Morton DL (1984) Clinical thermochemotherapy. A controlled trial in advanced cancer patients. Cancer 53:863–868

    Article  PubMed  CAS  Google Scholar 

  46. Sugarbaker ER, McBride CM (1976) Survival and regional disease control after isolation perfusion for invasive stage I melanoma of the extremities. Cancer 37:188–198

    Article  PubMed  CAS  Google Scholar 

  47. Sutherland CM, Mather FJ, Krementz ET (1987) Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet 164:111–118

    PubMed  CAS  Google Scholar 

  48. Tonak J, Hermanek P, Banz H, Groitl H (1979) Cytotoxics and hyperthermic perfusion: a preliminary study. Cancer Treat Rev 6:135–141

    Article  PubMed  Google Scholar 

  49. Tonak J, Hohenbergen W, Göhl J (1984) Die isolierte hyper-therme Extremitätenperfusion bei malignen Melanomen und Weichgewebssarkomen. Chirurg 55:499–504

    PubMed  CAS  Google Scholar 

  50. Van OS J, Schraffordt-Koops H, Oldhoff J (1985) Dosimetry of cytostatics in hyperthermic regional isolated perfusion. Cancer 55:698–701

    Article  PubMed  Google Scholar 

  51. Wagner DE (1976) A retrospective study of regional perfusion for melanoma. Arch Surg 111:410–413

    PubMed  CAS  Google Scholar 

  52. Wieberding J, Benckhuysen C, Braat RP, Van Slooten EA, Olthuis GAA (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18:905–910

    Article  Google Scholar 

Download references

Authors
  1. F. Truchetet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Grosshans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Kretz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Friedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Chartier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut National de la Santé et de la Recherche Médicale, Laboratoire de Thermologie Biomédicale Université Louis Pasteur, 11, rue Humann, 67085, Strasbourg Cedex, France

    Michel Gautherie

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Truchetet, F., Grosshans, E., Kretz, J.C., Friedel, J., Chartier, C. (1990). Combined Hyperthermia and Chemotherapy for Malignant Melanoma of the Limbs. In: Gautherie, M. (eds) Interstitial, Endocavitary and Perfusional Hyperthermia. Clinical Thermology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74640-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74640-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74642-0

  • Online ISBN: 978-3-642-74640-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation